Related Experiment Videos
Barbiturate-induced coma therapy for focal cerebral ischemia. Effect after temporary and permanent MCA occlusion
Abstract:
The authors have studied the therapeutic effect of barbiturate coma following middle cerebral artery (MCA) occlusion in primates. The relationship of the efficacy of barbiturate protection to the presence or absence of recirculation was examined. Barbiturate therapy was begun 30 minutes after MCA occlusion. The findings were as follows: 1) barbiturate-induced coma, with its attendant monitoring, was safely tolerated by primates for 96 hours; 2) 6 hours of MCA occlusion followed by recirculation resulted in a neurological deficit that was worse than the neurological deficit produced by permanent MCA occlusion; 3) barbiturate-induced coma for 96 hours, initiated 30 minutes after the onset of MCA occlusion, in the absence of reperfusion, was in fact detrimental; 4) barbiturate-induced coma for 96 hours, initiated 30 minutes after MCA occlusion, with the establishment of reperfusion at 6 hours, provided nearly complete protection from ischemic damage.
Insights
Barbiturate coma therapy for middle cerebral artery (MCA) occlusion in primates shows promise. When reperfusion occurs, barbiturate coma offers significant neuroprotection against ischemic damage.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Background:
- Middle cerebral artery (MCA) occlusion is a leading cause of ischemic stroke.
- Therapeutic hypothermia and barbiturate coma are potential neuroprotective strategies.
- The efficacy of barbiturate coma may depend on reperfusion status.
Purpose of the Study:
- To investigate the therapeutic effect of barbiturate coma following MCA occlusion in primates.
- To examine the relationship between barbiturate protection and the presence or absence of recirculation.
- To assess the safety and efficacy of prolonged barbiturate-induced coma.
Main Methods:
- Primates underwent middle cerebral artery (MCA) occlusion.
- Barbiturate therapy was initiated 30 minutes post-occlusion.
- Animals were monitored during 96-hour barbiturate-induced coma.
- Neurological deficits were assessed in relation to reperfusion status.
Main Results:
- Barbiturate-induced coma was safely tolerated for 96 hours in primates.
- MCA occlusion followed by recirculation led to worse neurological deficits than permanent occlusion.
- Barbiturate coma without reperfusion was detrimental.
- Barbiturate coma with reperfusion at 6 hours provided near-complete protection from ischemic damage.
Conclusions:
- Barbiturate coma therapy is safe for prolonged use in primates.
- The efficacy of barbiturate coma for MCA occlusion is critically dependent on reperfusion.
- Early reperfusion combined with barbiturate coma offers significant neuroprotection.